BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15500768)

  • 1. [The expression of cluster of differentiation 44 variant 6 and fibronectin in lacrimal gland tumors].
    Niu YJ; Liu FL; Yang WY; Lin H; Wang HY
    Zhonghua Yan Ke Za Zhi; 2004 Sep; 40(9):620-4. PubMed ID: 15500768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study on expression of CD44V6 and PCNA in squamous cell carcinomas].
    Niu Y; Liu F; Wang H
    Zhonghua Yan Ke Za Zhi; 2001 Nov; 37(6):451-4. PubMed ID: 11840756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
    Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
    Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adhesion molecule CD44v6 is associated with a high risk for local recurrence in adult soft tissue sarcomas.
    Maula S; Huuhtanen RL; Blomqvist CP; Wiklund TA; Laurila P; Ristamäki R
    Br J Cancer; 2001 Jan; 84(2):244-52. PubMed ID: 11161384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of CD44 isoform expression in thymic epithelial neoplasms.
    Sonobe S; Miyamoto H; Nobukawa B; Izumi H; Futagawa T; Ishikawa N; Yamazaki A; Uekusa T; Abe H; Suda K
    Cancer; 2005 May; 103(10):2015-22. PubMed ID: 15830350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of galectin-3 and CD44v6 expression in differential diagnosis of thyroid nodules].
    Wang LH; Zhao YJ; Wang XY; Yuan P; Xu WQ; Xiao JC; Xu JP; Luo BR
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):547-50. PubMed ID: 16438854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of fibronectin and CD44v6 expression with invasive growth and metastasis of liver cancer.
    Jha RK; Ma Q; Chen S; Sha H; Ding S
    Cancer Invest; 2009 Mar; 27(3):324-8. PubMed ID: 19194823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of CD44v6 protein expression in intraductal papilloma and its malignant transformation of breast].
    He JH; Liang XM; Hou JH; Huan YL; Wu QL; Xiao YB
    Ai Zheng; 2002 Jun; 21(6):615-8. PubMed ID: 12452061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of CD44v6 expression in gynecologic malignancies.
    Hong SC; Song JY; Lee JK; Lee NW; Kim SH; Yeom BW; Lee KW
    J Obstet Gynaecol Res; 2006 Aug; 32(4):379-86. PubMed ID: 16882263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered CD44 variant 6 expression in FIGO stage IB cervical carcinoma.
    Ayhan A; Baykal C; Al A; Ayhan A
    Gynecol Oncol; 2001 Dec; 83(3):569-74. PubMed ID: 11733974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary malignant mixed tumors of the lacrimal gland. Report of 10 cases.
    Henderson JW; Farrow GM
    Ophthalmology; 1980 Jun; 87(6):466-75. PubMed ID: 7413135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma.
    Yokoyama Y; Hiyama E; Murakami Y; Matsuura Y; Yokoyama T
    Cancer; 1999 Nov; 86(9):1691-9. PubMed ID: 10547541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship of the expression of CD44v6 and paxillin to the prognosis of non-small cell lung carcinoma].
    Zuo W; Li H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):484-5. PubMed ID: 12910696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The expression of MMP-2 and MMP-9 in adenoid cystic carcinoma of lacrimal gland].
    Zhang L; Zhang H; Song GX; Lin TT; Xu GC; Zhu LM
    Zhonghua Yan Ke Za Zhi; 2013 Jan; 49(1):58-63. PubMed ID: 23601468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
    Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
    Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of cell adhesion molecule (CD44V6) in thyroid tumors and its significance].
    Li L; Lin L; Qiu J
    Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):677-80. PubMed ID: 11769722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and pathological analysis of 151 cases of tumors in lacrimal fossa].
    Bi YW; Chen RJ
    Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):877-81. PubMed ID: 16271170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levels and clinical significance of CD44 (intron 9) and CD44v6 in malignant cerebroma].
    Gao H; Chen H; Zhang Z; Jiang T
    Zhonghua Wai Ke Za Zhi; 2002 Feb; 40(2):94-6. PubMed ID: 11955388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma.
    Stokes GN; Shelton JB; Zahn CM; Kendall BS
    Gynecol Oncol; 2002 Jan; 84(1):58-61. PubMed ID: 11748977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.